ASRT
Price
$0.71
Change
+$0.02 (+2.90%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
91.13M
21 days until earnings call
CPHI
Price
$1.84
Change
+$0.14 (+8.24%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
18.31M
Interact to see
Advertisement

ASRT vs CPHI

Header iconASRT vs CPHI Comparison
Open Charts ASRT vs CPHIBanner chart's image
Assertio Holdings
Price$0.71
Change+$0.02 (+2.90%)
Volume$998
Capitalization91.13M
China Pharma Holdings
Price$1.84
Change+$0.14 (+8.24%)
Volume$226
Capitalization18.31M
ASRT vs CPHI Comparison Chart in %
Loading...
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASRT vs. CPHI commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASRT is a StrongBuy and CPHI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ASRT: $0.69 vs. CPHI: $1.70)
Brand notoriety: ASRT and CPHI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ASRT: 58% vs. CPHI: 219%
Market capitalization -- ASRT: $91.13M vs. CPHI: $18.31M
ASRT [@Pharmaceuticals: Other] is valued at $91.13M. CPHI’s [@Pharmaceuticals: Other] market capitalization is $18.31M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASRT’s FA Score shows that 0 FA rating(s) are green whileCPHI’s FA Score has 0 green FA rating(s).

  • ASRT’s FA Score: 0 green, 5 red.
  • CPHI’s FA Score: 0 green, 5 red.
According to our system of comparison, CPHI is a better buy in the long-term than ASRT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASRT’s TA Score shows that 5 TA indicator(s) are bullish while CPHI’s TA Score has 3 bullish TA indicator(s).

  • ASRT’s TA Score: 5 bullish, 3 bearish.
  • CPHI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ASRT is a better buy in the short-term than CPHI.

Price Growth

ASRT (@Pharmaceuticals: Other) experienced а +1.88% price change this week, while CPHI (@Pharmaceuticals: Other) price change was -2.58% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +55.51%. For the same industry, the average monthly price growth was +85.18%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

ASRT is expected to report earnings on Nov 06, 2025.

CPHI is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+55.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASRT($91.1M) has a higher market cap than CPHI($18.3M). ASRT YTD gains are higher at: -21.077 vs. CPHI (-26.882). CPHI has less debt than ASRT: CPHI (5.39M) vs ASRT (39.7M).
ASRTCPHIASRT / CPHI
Capitalization91.1M18.3M498%
EBITDA-222.9MN/A-
Gain YTD-21.077-26.88278%
P/E Ratio1.21N/A-
Revenue152MN/A-
Total Cash73.4MN/A-
Total Debt39.7M5.39M736%
FUNDAMENTALS RATINGS
ASRT vs CPHI: Fundamental Ratings
ASRT
CPHI
OUTLOOK RATING
1..100
710
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
6154
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CPHI's Valuation (43) in the Pharmaceuticals Generic industry is somewhat better than the same rating for ASRT (81) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew somewhat faster than ASRT’s over the last 12 months.

CPHI's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as ASRT (100) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to ASRT’s over the last 12 months.

ASRT's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as CPHI (97) in the Pharmaceuticals Generic industry. This means that ASRT’s stock grew similarly to CPHI’s over the last 12 months.

CPHI's Price Growth Rating (54) in the Pharmaceuticals Generic industry is in the same range as ASRT (61) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to ASRT’s over the last 12 months.

ASRT's P/E Growth Rating (99) in the Pharmaceuticals Major industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that ASRT’s stock grew similarly to CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASRTCPHI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 18 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ASRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACAD21.570.55
+2.62%
ACADIA Pharmaceuticals
NWG13.550.15
+1.12%
NatWest Group plc
ACU44.080.22
+0.50%
Acme United Corp
CGBD13.890.05
+0.36%
Carlyle Secured Lending
BRFH3.40N/A
N/A
Barfresh Food Group

ASRT and

Correlation & Price change

A.I.dvisor tells us that ASRT and OGI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASRT and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASRT
1D Price
Change %
ASRT100%
-0.15%
OGI - ASRT
28%
Poorly correlated
+0.70%
AQST - ASRT
28%
Poorly correlated
+8.97%
TLRY - ASRT
27%
Poorly correlated
+14.37%
INDV - ASRT
26%
Poorly correlated
-2.64%
SNOA - ASRT
26%
Poorly correlated
+2.89%
More

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and TAK have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
-3.41%
TAK - CPHI
26%
Poorly correlated
+0.73%
HCM - CPHI
24%
Poorly correlated
+2.32%
PAHC - CPHI
22%
Poorly correlated
+4.22%
SXTC - CPHI
22%
Poorly correlated
+4.73%
ASRT - CPHI
22%
Poorly correlated
-0.15%
More